Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | DRTS | OCUL |
|---|---|---|
| Price | $14.89 | $7.25 |
| Change today | ▲ 0.81% | ▲ 4.17% |
| Market cap | $1.37B | $1.59B |
| Return, 3 months | +16.7% | -29.8% |
| Return, year to date | +200.8% | -40.3% |
| Return, 1 year | +252.8% | -33.9% |
| P/E (TTM) | -14.3 | -5.2 |
| P/B | 31.2 | 3.1 |
| P/E percentile vs own 5y | 24th | – |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | -18.5% |
| Net profit growth (YoY) | -353.0% | -37.4% |
| Gross margin | – | 87.3% |
| Operating margin | – | -519.8% |
| Net margin | – | -511.9% |
| Return on equity | – | – |
| Analyst target vs. price | +54.5% | +252.7% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 53 | 29 |
| 30-day volatility | 34.9% | 84.0% |
| Max drawdown, 1 year | -23.9% | -57.3% |
| Trend read | Strong uptrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
